FDA Announces Proposed Rule Regarding Laboratory Developed Tests

The highly anticipated rule, which would make explicit that LDTs are medical devices subject to FDA oversight, proposes to end the agency’s general enforcement discretion approach to such devices….
By: Jones Day
Previous Story

October is Cybersecurity Awareness Month – Takeaways for the Entire Year

Next Story

French Parliament Takes Steps to Regulate NFT Games